Literature DB >> 14685062

Didanosine-ribavirin combination: synergistic combination in vitro, but high potential risk of toxicity in vivo.

Raffaele Bruno, Paolo Sacchi, Gaetano Filice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14685062     DOI： 10.1097/01.aids.0000096864.36052.16

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.

Authors:  Frauke Christ; Stephen Shaw; Jonas Demeulemeester; Belete A Desimmie; Arnaud Marchand; Scott Butler; Wim Smets; Patrick Chaltin; Mike Westby; Zeger Debyser; Chris Pickford
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study.

Authors:  M Rodriguez-Torres; F J Torriani; V Soriano; M J Borucki; E Lissen; M Sulkowski; D Dieterich; K Wang; J-M Gries; P G Hoggard; D Back
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.